Skip to content

Clinical trials

Phase 2 Virus Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Virus Diseases Phase: Phase 2 Country / region: United States Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20081
20092
20102
20134
20141
20153
20162
20173
20181
20193
20207
20215
20223
20236
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated6
Recruiting4
Active, not recruiting4
Withdrawn4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.9
Children's Hospital Medical Center, Cincinnati5
GlaxoSmithKline4
Medicago3
U.S. Army Medical Research and Development Command3
National Institute of Allergy and Infectious Diseases (NIAID)2
Pfizer2
Restorbio Inc.2
Seqirus2
Verrica Pharmaceuticals Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Virus Diseases55
Infections13
COVID-1911
Influenza, Human10
RNA Virus Infections9
Respiratory Tract Infections9
Coronavirus Infections8
Respiratory Tract Diseases8
DNA Virus Infections6
Liver Diseases5

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.